BackTurnstone Biologics Overview

Turnstone Biologics Accounts Payable

Turnstone Biologics's accounts payable is $2.7M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.69M
↑ 80.82% YoYΔ $1.20M vs prior year quarter

Peer average / median

Loading

Turnstone Biologics Accounts Payable History

Loading

Turnstone Biologics vs. peers: Accounts Payable Comparison

Loading

Turnstone Biologics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Turnstone Biologics (TSBX) FAQ

As of the most recent data (June 2025), TSBX shows a accounts payable of $2.7M. That compares with $1.5M in the prior-year period — up 80.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TSBX's accounts payable is now $2.7M (was $1.5M) — a 80.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Turnstone Biologics is outperforming or lagging.

Tracking TSBX's accounts payable over time shows whether Turnstone Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.7M That compares with $1.5M in the prior-year period — up 80.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Turnstone Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.7M) with ownership activity and broader fundamentals.